| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $3.13B | $2.63B | $2.17B |
| YoY Revenue Growth % | +19.2% | +21.1% | — |
| Gross Profit | $2.62B | $2.23B | — |
| Gross Margin % | 83.8% | 85.0% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $7.4M | -$67.6M | -$200.9M |
| Operating Margin % | 0.2% | -2.6% | -9.3% |
| Net Income (GAAP) | $45.9M | $4.6M | -$176.3M |
| EBITDA (Normalized) | $49.9M | -$37.3M | -$122.8M |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $760.7M | $598.6M | $351.0M |
| Capital Expenditures (CapEx) | $53.2M | $37.9M | $97.7M |
| Free Cash Flow (FCF) | $707.6M | $560.7M | $253.3M |
| FCF Margin % | 22.6% | 21.3% | 11.7% |
| Return on Invested Capital (ROIC %) | 0.3% | -2.4% | -4.0% |
| Cash & Short-Term Equivalents | $882.2M | $512.7M | — |
| Total Debt (Short + Long Term) | $804.6M | $849.4M | $1.54B |
| Total Stockholders' Equity | $2.07B | $1.91B | $3.15B |